Financhill
Back

Opus Genetics Vs. Syros Pharmaceuticals Industry Stock Comparison

Sell
37

IRD
Opus Genetics

Last Price:
1.07
Seasonality Move:
3.61%
Sell
33

SYRS
Syros Pharmaceuticals

Last Price:
0.27
Seasonality Move:
17.91%
Sell
37
Opus Genetics (IRD) is a Sell

Is Opus Genetics a Buy, Sell or Hold?

  • The current Opus Genetics [IRD] share price is $1.09. The Score for IRD is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • IRD is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
33
Syros Pharmaceuticals (SYRS) is a Sell

Is Syros Pharmaceuticals a Buy, Sell or Hold?

  • The current Syros Pharmaceuticals [SYRS] share price is $0.36. The Score for SYRS is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.
  • SYRS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

IRD Stock Price Chart

What is Opus Genetics's stock price today?

  • The Opus Genetics share price today is $1.09
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and IRD is experiencing slight selling pressure.

SYRS Stock Price Chart

What is Syros Pharmaceuticals's stock price today?

  • The Syros Pharmaceuticals share price today is $0.36
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SYRS is experiencing selling pressure, which indicates risk of future bearish movement.

IRD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 38.95 Sell
Chaikin Money Flow: -114040 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.13 - 1.29) Sell
Bollinger Bands (100): (1.16 - 1.72) Sell

SYRS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0 Sell
Relative Strength Index (14 RSI): 28.2 Sell
Chaikin Money Flow: -25163664 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.72 - 2.72) Sell
Bollinger Bands (100): (1.39 - 5.03) Sell

IRD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.14 Sell
20-day SMA: 1.21 Sell
50-day SMA: 1.26 Sell
200-day SMA: 1.72 Sell
8-day EMA: 1.14 Sell
20-day EMA: 1.19 Sell
50-day EMA: 1.27 Sell
200-day EMA: 1.77 Sell

SYRS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.36 Sell
20-day SMA: 2.29 Sell
50-day SMA: 2.04 Sell
200-day SMA: 4.56 Sell
8-day EMA: 2.15 Sell
20-day EMA: 2.24 Sell
50-day EMA: 2.37 Sell
200-day EMA: 3.78 Sell

Opus Genetics Earnings Growth & IRD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.60 per share, and an increase next year of $0.04 per share.

Syros Pharmaceuticals Earnings Growth & SYRS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.15 per share, and a decrease next year of $1.03 per share.

Opus Genetics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Syros Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):